122 related articles for article (PubMed ID: 33471524)
1. How a Fragment Draws Attention to Selectivity Discriminating Features between the Related Proteases Trypsin and Thrombin.
Sandner A; Ngo K; Schiebel J; Pizarroso AIM; Schmidt L; Wenzel B; Steinmetzer T; Ostermann A; Heine A; Klebe G
J Med Chem; 2021 Feb; 64(3):1611-1625. PubMed ID: 33471524
[TBL] [Abstract][Full Text] [Related]
2. Protein-Induced Change in Ligand Protonation during Trypsin and Thrombin Binding: Hint on Differences in Selectivity Determinants of Both Proteins?
Ngo K; Collins-Kautz C; Gerstenecker S; Wagner B; Heine A; Klebe G
J Med Chem; 2020 Mar; 63(6):3274-3289. PubMed ID: 32011145
[TBL] [Abstract][Full Text] [Related]
3. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
4. Impact of ligand and protein desolvation on ligand binding to the S1 pocket of thrombin.
Biela A; Khayat M; Tan H; Kong J; Heine A; Hangauer D; Klebe G
J Mol Biol; 2012 May; 418(5):350-66. PubMed ID: 22366545
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of human alpha-thrombin complexed with hirugen and p-amidinophenylpyruvate at 1.6 A resolution.
Chen Z; Li Y; Mulichak AM; Lewis SD; Shafer JA
Arch Biochem Biophys; 1995 Sep; 322(1):198-203. PubMed ID: 7574675
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for selectivity of a small molecule, S1-binding, submicromolar inhibitor of urokinase-type plasminogen activator.
Katz BA; Mackman R; Luong C; Radika K; Martelli A; Sprengeler PA; Wang J; Chan H; Wong L
Chem Biol; 2000 Apr; 7(4):299-312. PubMed ID: 10779411
[TBL] [Abstract][Full Text] [Related]
7. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
Bhunia SS; Roy KK; Saxena AK
J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.
Ganesh V; Lee AY; Clardy J; Tulinsky A
Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of the structural basis for the slow reactivity of thrombin with plasminogen activator inhibitor-1.
Rezaie AR
Biochemistry; 1998 Sep; 37(38):13138-42. PubMed ID: 9748320
[TBL] [Abstract][Full Text] [Related]
10. Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors.
Katz BA; Elrod K; Verner E; Mackman RL; Luong C; Shrader WD; Sendzik M; Spencer JR; Sprengeler PA; Kolesnikov A; Tai VW; Hui HC; Breitenbucher JG; Allen D; Janc JW
J Mol Biol; 2003 May; 329(1):93-120. PubMed ID: 12742021
[TBL] [Abstract][Full Text] [Related]
11. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
12. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
[TBL] [Abstract][Full Text] [Related]
13. The role of the insertion loop around tryptophan 148 in tthe activity of thrombin.
DiBella EE; Scheraga HA
Biochemistry; 1996 Apr; 35(14):4427-33. PubMed ID: 8605192
[TBL] [Abstract][Full Text] [Related]
14. Comparative binding energy analysis considering multiple receptors: a step toward 3D-QSAR models for multiple targets.
Murcia M; Morreale A; Ortiz AR
J Med Chem; 2006 Oct; 49(21):6241-53. PubMed ID: 17034130
[TBL] [Abstract][Full Text] [Related]
15. Structure of thrombin complexed with selective non-electrophilic inhibitors having cyclohexyl moieties at P1.
Krishnan R; Mochalkin I; Arni R; Tulinsky A
Acta Crystallogr D Biol Crystallogr; 2000 Mar; 56(Pt 3):294-303. PubMed ID: 10713516
[TBL] [Abstract][Full Text] [Related]
16. The Na+ binding site of thrombin.
Di Cera E; Guinto ER; Vindigni A; Dang QD; Ayala YM; Wuyi M; Tulinsky A
J Biol Chem; 1995 Sep; 270(38):22089-92. PubMed ID: 7673182
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin.
Féthière J; Tsuda Y; Coulombe R; Konishi Y; Cygler M
Protein Sci; 1996 Jun; 5(6):1174-83. PubMed ID: 8762149
[TBL] [Abstract][Full Text] [Related]
18. Factorising ligand affinity: a combined thermodynamic and crystallographic study of trypsin and thrombin inhibition.
Dullweber F; Stubbs MT; Musil D; Stürzebecher J; Klebe G
J Mol Biol; 2001 Oct; 313(3):593-614. PubMed ID: 11676542
[TBL] [Abstract][Full Text] [Related]
19. Comparative molecular modeling analysis of-5-amidinoindole and benzamidine binding to thrombin and trypsin: specific H-bond formation contributes to high 5-amidinoindole potency and selectivity for thrombin and factor Xa.
Zhou Y; Johnson ME
J Mol Recognit; 1999; 12(4):235-41. PubMed ID: 10440994
[TBL] [Abstract][Full Text] [Related]
20. Energetic and structural consequences of perturbing Gly-193 in the oxyanion hole of serine proteases.
Bobofchak KM; Pineda AO; Mathews FS; Di Cera E
J Biol Chem; 2005 Jul; 280(27):25644-50. PubMed ID: 15890651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]